NCT05186688

Braining - Physical Exercise in Psychiatry - Evaluation of Feasibility, and Health Among Patients

Completed NA Last updated 9 December 2024

What this trial tests

NA trial testing Braining in Mental Disorder in 22 participants. Completed in 30 September 2023.

Timeline

2 March 2022

Primary endpoint
31 July 2022

30 September 2023

Quick facts

Lead sponsor	Region Stockholm
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	22
Start date	2 March 2022
Primary completion	31 July 2022
Estimated completion	30 September 2023
Sites	1 location across Sweden

Drugs / interventions tested

• Braining

Conditions studied

• Mental Disorder — all drugs for Mental Disorder →

Sponsor

Region Stockholm — full company profile →

Who can join

18 and older, any sex, with Mental Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Physical exercise (PE) shows beneficial effects on somatic and psychiatric symptoms. "Braining" is a clinical invention where psychiatric staff exercise together with patients to help patients start and execute PE regularly. In the present study the feasibility of the intervention will be evaluated, how Braining is perceived, and preliminary effects on health and physical activity among patients. The investigators hypothesize that patients' health and physical activity will increase after participation in Braining at the unit. Braining will be implemented at two psychiatric pilot units in Region Stockholm, Sweden. During 6 months patients will be included and treated in 12 weeks PE intervention periods. To measure feasibility patients will answer self-rating questionnaires and be invited to semi structured interviews after receiving the intervention. Health will be measured by physical examination and blood test as well as self-ratings of depression, anxiety, sleep, hypomania, and quality of life before the intervention, every 4 weeks during the intervention, post the intervention, and at follow-up 12 months post the intervention. Physical activity will be rated before, during, after the intervention and at follow-up 12 months post the intervention using International Physical Activity Questionnaires (IPAQ) and Actigraph. All patients that fulfill inclusion criteria at the units will be invited to participate in the study, approximately 50 individuals in total.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.